FDA Announces Meeting of Clinical Hold Review Committee and Request for Submissions

Summary

The Food and Drug Administration (FDA) is hosting a meeting of the clinical hold review committee to review clinical holds on investigational new drug trials. The committee, established in 1991, will consider submissions from interested drug companies regarding trials placed on hold in the past year.